KELSEY MADDEN: Open Payments
NPI 1922605278 · QUEEN CREEK, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,060 in 171 payments from 21 companies in 2025. Trend: 2023 $2,026 · 2024 $2,062 · 2025 $3,060
Food & beverage: $2,955Education: $105
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 22 | $475 |
| Janssen Biotech, Inc. | 17 | $391 |
| Regeneron Healthcare Solutions, Inc. | 17 | $348 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 15 | $255 |
| Amgen Inc. | 9 | $240 |
| Incyte Corporation | 17 | $223 |
| UCB, Inc. | 12 | $211 |
| ABBVIE INC. | 18 | $182 |
| Novartis Pharmaceuticals Corporation | 10 | $159 |
| MAYNE PHARMA COMMERCIAL LLC | 8 | $115 |
Products named: TREMFYA, DUPIXENT, NEMLUVIO, OPZELURA, Bimzelx, SKYRIZI, Winlevi, COSENTYX.
Industry payments across AZ — which companies pay providers there.
